ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Health Technology

Olympus Corp.

  • 4,010.00 JPY
  • +10.00
  • +0.25%
  • Japan
    Apr 20, 2018
  • Ticker
  • Prev. close
  • Market cap (JPY)
  • Market cap (USD)
  • Shares

Business Summary

Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2017 JPYUSD
Gross Profit490,658M4,531.06M
Operating income76,487M706.33M
Income before tax81,686M754.34M
Net income78,191M722.06M
Diluted EPS228.372.10
Dividends Per Share280.25
Total Assets991,062M8,894.03M
Total liabilities560,182M5,027.20M
Total equity429,361M3,853.19M
Operating cash flow90,194M832.91M
Currency in JPYCurrency in USD

Historical Data

 Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue 743,851M 713,286M 764,671M 804,578M 748,050M
Gross Profit 380,414M 442,623M 489,040M 534,482M 490,658M
Operating income 35,077M 73,445M 91,712M 104,464M 76,487M
Income before tax 19,142M 16,425M 8,934M 70,800M 81,686M
Net income 8,020M 13,627M -8,737M 62,594M 78,191M
EBITDA 78,659M 119,752M 142,352M 154,243M 129,787M
Diluted EPS 28.96 41.04 -25.53 182.84 228.37
Dividends Per Share 0 0 10 17 28
Total Assets 960,082M 1,027.47B 1,081.55B 1,000.61B 991,062M
Total liabilities 807,675M 696,191M 724,297M 616,331M 560,182M
Total equity 149,105M 329,634M 355,722M 382,787M 429,361M
Operating cash flow 25,233M 72,388M 66,811M 48,621M 90,194M
 Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue 8,972.09M 7,120.64M 6,960.63M 6,700.11M 6,907.99M
Gross Profit 4,588.43M 4,418.65M 4,451.62M 4,450.89M 4,531.06M
Operating income 423.08M 733.19M 834.83M 869.92M 706.33M
Income before tax 230.88M 163.96M 81.32M 589.58M 754.34M
Net income 96.73M 136.03M -79.53M 521.25M 722.06M
EBITDA 948.76M 1,195.46M 1,295.79M 1,284.45M 1,198.54M
Diluted EPS 0.34 0.40 -0.23 1.52 2.10
Dividends Per Share 0 0 0.09 0.14 0.25
Total Assets 10,211.46M 9,976.93M 9,018.56M 8,902.65M 8,894.03M
Total liabilities 8,590.46M 6,760.12M 6,039.58M 5,483.61M 5,027.20M
Total equity 1,585.88M 3,200.79M 2,966.20M 3,405.72M 3,853.19M
Operating cash flow 304.35M 722.64M 608.16M 404.89M 832.91M

Valuation Measures

Mar 2017
Operating margin10.22%
Profit margin10.45%

Key executives

  • Executive President & Representative Director: Hiroyuki Sasa
  • Chief Financial Officer, Director & Executive VP: Yasuo Takeuchi
  • Director & Chief Technology Officer: Haruo Ogawa
  • Global Chief Compliance Officer: Caroline West
  • Executive Officer: Hitoshi Kawada


  • Harris Associates LP (5.2%)
  • Sony Corp. (5.0%)
  • Northern Cross LLC (4.1%)
  • Nomura Asset Management Co., Ltd. (4.0%)
  • Nippon Life Insurance Co. (3.8%)
  • Asset Management One Co., Ltd. (3.3%)
  • Mitsubishi UFJ Financial Group, Inc. (3.2%)
  • Fidelity Management & Research Co. (2.7%)
  • BlackRock Fund Advisors (2.3%)
  • Nikko Asset Management Co., Ltd. (2.0%)

Contact Details

  • Website:
  • Address: Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Tokyo, 163-0914, Japan
  • Phone: +81.3.3340.2111

Related Companies

  • Olympus Restricted Stock Compensation Plan
  • Olympus NDT Systems, Inc.
  • YuanLi Instrument Co. Ltd.
  • Olympus Service Facility Portugal - Tecnologias Opticas e Digi
  • Olympus Korea Service Co., Ltd.
  • Olympus Optical do Brasil Ltda.
  • Olympus Moscow LLC
  • Olympus Europa SE & Co. KG
  • Olympus Europa Property Management GmbH
  • Olympus doo za trgovinu
  • Olympus Corporation of the Americas Pennsylvania
  • Olympus doo Beograd
  • Olympus Czech Group sro
  • Olympus Slovenija Trgovina doo
  • Olympus Iberia SAU
  • Olympus Communications Technology of America, Inc.
  • Vichen B&I Co., Ltd.
  • Gyrus ACMI, Inc.
  • Olympus Estonia OU
  • Olympus (Thailand) Co. Ltd.
  • Olympus Australia Pty Ltd.
  • Olympus Europa Management SE
  • Olympus BH doo
  • Olympus Medical Systems Vietnam Co. Ltd.
  • Olympus Schweiz AG
  • Olympus Canada, Inc.
  • Olympus Scientific Solutions Americas, Inc.
  • Olympus (Guangzhou) Industrial Ltd.
  • Olympus Lithuania UAB
  • Olympus Latvia SIA


  • Stryker Corporation
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Medtronic plc
  • Panasonic Corporation
  • Sony Corporation
  • Canon Inc.
  • General Electric Company
  • FUJIFILM Holdings Corp
  • Danaher Corporation
  • Nikon Corp.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Carl Zeiss Meditec AG
  • CONMED Corporation
  • Mauna Kea Technologies SA Class O
  • Merit Medical Systems, Inc.
  • Cogentix Medical Inc
  • Intuitive Surgical, Inc.
  • Cantel Medical Corp.
  • Cooper Companies, Inc.
  • GoPro, Inc. Class A
  • STERIS Plc
  • Motus GI Holdings, Inc.
  • TSO3 Inc.
  • Microbot Medical Inc
  • Mistras Group, Inc.
  • Check-Cap Ltd.
  • Kinko Optical Co. Ltd.
Last Updated on 20 Apr, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media